T1	Procedure 4 28	anti-coagulation therapy
T2	Drug 41 52	rivaroxaban
T3	Negation 30 40	apart from
R1	Has_negation Arg1:T2 Arg2:T3	
T4	Condition 76 92	Hypersensitivity
T5	Condition 96 103	allergy
T6	Drug 107 127	factor Xa inhibitors
*	OR T5 T4
T7	Scope 76 103	Hypersensitivity or allergy
R2	AND Arg1:T7 Arg2:T6	
T8	Condition 129 157	Acute bacterial endocarditis
T9	Condition 159 176	Bleeding disorder
T10	Condition 198 213	active bleeding
T11	Condition 215 237	Gastrointestinal ulcer
T12	Condition 215 231;241 246	Gastrointestinal tumor
*	OR T11 T12
T13	Condition 248 267	Hepatic dysfunction
T14	Observation 283 296	bleeding risk
T15	Qualifier 273 282	increased
R3	Has_qualifier Arg1:T14 Arg2:T15	
R4	AND Arg1:T14 Arg2:T13	
T16	Condition 298 311	Renal failure
T17	Procedure 334 342	dialysis
*	OR T16 T17
T18	Pregnancy_considerations 344 372	Pregnancy and breast feeding
T19	Procedure 374 385	Gastrectomy
T20	Procedure 387 412	biliopancreatic diversion
T21	Procedure 427 437	re-routing
T22	Procedure 414 423	resection
T23	Qualifier 441 457	small intestines
*	OR T21 T22
T24	Scope 414 437	resection or re-routing
R5	Has_qualifier Arg1:T24 Arg2:T23	
*	OR T24 T20 T19
T25	Device 459 471	Feeding tube
T26	Observation 480 494	blood donation
T27	Measurement 532 556	alanine-aminotransferase
T28	Measurement 558 562	ALAT
T29	Measurement 565 591	aspartate-aminotransferase
T30	Measurement 593 597	ASAT
T31	Measurement 600 626	gamma-glutamyl transferase
T32	Measurement 628 635	gammaGT
T33	Measurement 638 657	alkalic phosphatase
T34	Measurement 659 661	AP
T35	Measurement 664 673	bilirubin
T36	Measurement 675 682	amylase
T37	Measurement 684 690	lipase
T38	Measurement 692 702	cystatin C
T39	Measurement 704 714	creatinine
T40	Measurement 716 738	white blood cell count
T41	Measurement 740 751	haemoglobin
T42	Measurement 753 767	platelet count
T43	Measurement 769 786	prothrombin time,
T44	Measurement 787 791	aPTT
T45	Measurement 793 803	fibrinogen
T46	Measurement 805 818	thrombin time
T47	Measurement 820 830	factors II
T48	Measurement 820 827;831 832	factors V
T49	Measurement 820 827;833 836	factors VII
T50	Measurement 820 827;841 842	factors X
R6	Subsumes Arg1:T27 Arg2:T28	
R7	Subsumes Arg1:T29 Arg2:T30	
R8	Subsumes Arg1:T31 Arg2:T32	
R9	Subsumes Arg1:T33 Arg2:T34	
*	OR T27 T29 T31 T47 T49 T50 T48 T46 T45 T44 T43 T42 T41 T33 T35 T36 T37 T38 T39
T51	Scope 532 842	alanine-aminotransferase (ALAT), aspartate-aminotransferase (ASAT), gamma-glutamyl transferase (gammaGT), alkalic phosphatase (AP), bilirubin, amylase, lipase, cystatin C, creatinine, white blood cell count, haemoglobin, platelet count, prothrombin time, aPTT, fibrinogen, thrombin time, factors II,V,VII and X
T52	Value 496 509	Abnormalities
R10	Has_value Arg1:T51 Arg2:T52	
T53	Non-query-able 844 918	Use of therapeutic or recreational drugs influencing plasmatic coagulation
